Home / Inspections / 1049255

FDA Inspection 1049255 — Central California Blood Center

Central California Blood Center — FEI 3002963670

The FDA completed an inspection of Central California Blood Center on March 2, 2018 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 2, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fresno, CA (United States)

Facility

Other inspections at this facility

  • 1319874 (NAI Fri Apr 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108061 (NAI Fri Oct 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 967701 (NAI Mon Apr 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 856690 (NAI Mon Nov 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 797705 (NAI Mon Sep 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources